In the 20 years since the FDA’s approval of rituximab for rheumatoid arthritis, trials and real-world use of B-cell depleting therapies have resulted in surprising successes and unexpected setbacks in ...
A research team led by associate professors Yohei Funakoshi and Kimikazu Yakushijin and Professor Hironobu Minami of the ...
B-cell lymphoma may cause abdominal swelling, chest pressure, and bone weakening as lymphoma cells affect different organs. Treatments like chemotherapy and immunotherapy for B-cell lymphoma may ...
The pGen-SHM plot combines BCR generation probability and somatic hypermutation to track humoral immune recovery after stem cell transplantation. The approach has revealed distinct maturation patterns ...
Stanford Medicine researchers developed a two-part molecule that reprograms a key protein in B-cell lymphoma, causing ...
B-cell lymphoma is a type of non-Hodgkin lymphoma. It’s also the most common type of lymphoma. Approximately 85% of all lymphomas in the United States are B-cell lymphomas. Non-Hodgkin lymphomas are ...
Recognition of mixed autoimmune hemolytic anemia can help clinicians avoid treatment strategies appropriate for only warm or cold disease.
Stage 4 diffuse large B-cell lymphoma (DLBCL) is a rapidly growing lymphoma affecting at least one other organ outside the lymphatic system. Cancer is the unusual growth and spread of cells within the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results